Correlation Between Mechema Chemicals and Medigen Biotechnology

Can any of the company-specific risk be diversified away by investing in both Mechema Chemicals and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mechema Chemicals and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mechema Chemicals Int and Medigen Biotechnology, you can compare the effects of market volatilities on Mechema Chemicals and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mechema Chemicals with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mechema Chemicals and Medigen Biotechnology.

Diversification Opportunities for Mechema Chemicals and Medigen Biotechnology

0.31

Correlation Coefficient

Mechema Chemicals  Medigen Biotechnology

Weak diversification

The 3 months correlation between Mechema and Medigen is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Mechema Chemicals Int and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and Mechema Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mechema Chemicals Int are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of Mechema Chemicals i.e., Mechema Chemicals and Medigen Biotechnology go up and down completely randomly.

Pair Corralation between Mechema Chemicals and Medigen Biotechnology

Assuming the 90 days trading horizon Mechema Chemicals Int is expected to under-perform the Medigen Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Mechema Chemicals Int is 1.3 times less risky than Medigen Biotechnology. The stock trades about -0.05 of its potential returns per unit of risk. The Medigen Biotechnology is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  3,220  in Medigen Biotechnology on October 23, 2024 and sell it today you would earn a total of  40.00  from holding Medigen Biotechnology or generate 1.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Mechema Chemicals Int  vs.  Medigen Biotechnology

Mechema Chemicals Int

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mechema Chemicals Int has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Medigen Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Mechema Chemicals and Medigen Biotechnology

The main advantage of trading using opposite Mechema Chemicals and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mechema Chemicals position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.

The idea behind Mechema Chemicals Int and Medigen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.